A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer

A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer

Immune checkpoint inhibitors (ICIs) therapy has been successfully utilized in the treatment of multiple tumors, but only a fraction of patients with gastric cancer (GC) could greatly benefit from it. A recent study has shown that the tumor microenvironment (TME) can greatly affect the effect of immu...

Full description

Bibliographic Details
Main Authors: Xiang Xu, Lipeng Zhang, Yan Qian, Qian Fang, Yongbiao Xiao, Guizeng Chen, Guojing Cai, Alimujiang Abula, Zhao Wang, Ertao Zhai, Jianhui Chen, Shirong Cai, Hui Wu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
gastric cancer
tumor microenvironment
immune checkpoint inhibitor
immune risk signature
tumor mutation load
Online Access:https://www.mdpi.com/1424-8247/15/11/1401

Similar Items

Similar Items